Literature DB >> 18243645

Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

Steven Paul Woods1, Lisa M Moran, Catherine L Carey, Matthew S Dawson, Jennifer E Iudicello, Sarah Gibson, Igor Grant, J Hampton Atkinson.   

Abstract

Optimal adherence to antiretroviral medications is critical to the effective long-term management of HIV infection. Although prospective memory (ProM; i.e., "remembering to remember") has long been theorized to play an important role in medication adherence, no prior studies have evaluated whether HIV-associated ProM impairment possesses unique predictive value in this regard. Results from this study demonstrate a robust association between ProM impairment and self-reported medication management in 87 HIV-infected persons currently prescribed antiretroviral medications. Specifically, more frequent ProM complaints and performance deficits on both laboratory and semi-naturalistic ProM tasks were all independently related to poorer self-reported medication management. A series of hierarchical regression analyses revealed that HIV-associated ProM impairment accounted for a significant amount of variance in self-reported medication management beyond that which was explained by other factors known to predict nonadherence, including mood disorders, psychosocial variables, environmental structure, and deficits on a traditional battery of neuropsychological tests. Overall, these findings support the hypothesis that ProM captures a unique and largely untapped aspect of cognition that is germane to optimal medication adherence. The potential benefits of individualized remediation strategies that are informed by conceptual models of ProM and specifically target medication adherence warrant further exploration.

Entities:  

Mesh:

Year:  2008        PMID: 18243645      PMCID: PMC2408931          DOI: 10.1016/j.acn.2007.12.006

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  34 in total

Review 1.  Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Authors:  Carlo Federico Perno; Francesca Ceccherini-Silberstein; Andrea De Luca; Alessandro Cozzi-Lepri; Caterina Gori; Antonella Cingolani; Maria Concetta Bellocchi; Maria Paola Trotta; Paola Piano; Federica Forbici; Antonio Scasso; Vincenzo Vullo; Antonella d'Arminio Monforte; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

2.  Prospective and retrospective memory in normal ageing and dementia: a questionnaire study.

Authors:  G Smith; S Della Sala; R H Logie; E A Maylor
Journal:  Memory       Date:  2000-09

3.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

4.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

5.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

6.  Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.

Authors:  Steven Paul Woods; Julie D Rippeth; Alan B Frol; Joel K Levy; Elizabeth Ryan; Vicki M Soukup; Charles H Hinkin; Deborah Lazzaretto; Mariana Cherner; Thomas D Marcotte; Benjamin B Gelman; Susan Morgello; Elyse J Singer; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-09       Impact factor: 2.475

7.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Authors:  Julie D Rippeth; Robert K Heaton; Catherine L Carey; Thomas D Marcotte; David J Moore; Raul Gonzalez; Tanya Wolfson; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-01       Impact factor: 2.892

8.  Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Authors:  Nancy R Reynolds; Marcia A Testa; Linda G Marc; Margaret A Chesney; Judith L Neidig; Scott R Smith; Stefano Vella; Gregory K Robbins
Journal:  AIDS Behav       Date:  2004-06

Review 9.  Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Authors:  Fabrizio Starace; Adriana Ammassari; Maria Paola Trotta; Rita Murri; Patrizio De Longis; Crescenzo Izzo; Alfredo Scalzini; Antonella d'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

10.  Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.

Authors:  C J Reback; S Larkins; S Shoptaw
Journal:  AIDS Care       Date:  2003-12
View more
  58 in total

1.  Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Authors:  Catherine A Sumida; Emily J Van Etten; Francesca V Lopez; David P Sheppard; Eva Pirogovsky-Turk; Jody Corey-Bloom; J Vincent Filoteo; Steven P Woods; Paul E Gilbert; Maureen Schmitter-Edgecombe
Journal:  Arch Clin Neuropsychol       Date:  2019-10-24       Impact factor: 2.813

2.  Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Erica Weber; Alexandra S Rooney; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-02-02       Impact factor: 2.475

3.  Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Authors:  Doyle E Patton; Steven Paul Woods; Donald Franklin; Jordan E Cattie; Robert K Heaton; Ann C Collier; Christina Marra; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant
Journal:  AIDS Behav       Date:  2012-11

Review 4.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

5.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

6.  Prospective memory in Parkinson disease across laboratory and self-reported everyday performance.

Authors:  Erin R Foster; Mark A McDaniel; Grega Repovs; Tamara Hershey
Journal:  Neuropsychology       Date:  2009-05       Impact factor: 3.295

Review 7.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

8.  Medication management abilities are reduced in older persons living with HIV compared with healthy older HIV- controls.

Authors:  Sarah A Cooley; Robert H Paul; Beau M Ances
Journal:  J Neurovirol       Date:  2020-01-27       Impact factor: 2.643

9.  Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test.

Authors:  Amelia J Poquette; David J Moore; Ben Gouaux; Erin E Morgan; Igor Grant; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2012-10-25       Impact factor: 2.892

10.  Prospective memory deficits are associated with poorer everyday functioning in Parkinson's disease.

Authors:  Eva Pirogovsky; Steven Paul Woods; J Vincent Filoteo; Paul E Gilbert
Journal:  J Int Neuropsychol Soc       Date:  2012-07-30       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.